|Bid||0.0070 x 1442544500|
|Ask||0.0080 x 374767100|
|Day's range||0.0070 - 0.0080|
|52-week range||0.0060 - 0.0170|
|Beta (5Y monthly)||1.68|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||0.28|
With the business potentially at an important milestone, we thought we'd take a closer look at Medibio Limited's...
Medibio Limited (MEB or the Company)(ASX: MEB)(OTCPINK: MDBIF), is pleased to announce that it has received CE Mark approval for its sleep staging software, MEBsleep.